Our mission is opening a digital front door to a new kind of healthcare system, one that provides greater access to high quality, convenient and affordable care. No matter who a person is, where they come from, what they look like, or if they have insurance or not—Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care.

HIMS

Andrew Dudum

Chief Executive Officer

Melissa Baird

Chief Operating Officer

Soleil Boughton

Chief Legal Officer and Corporate Secretary

Yemi Okupe

Chief Financial Officer

Chief Executive Officer And Board Of Director

Alex Bard

Board Of Director

Dr. Toby Cosgrove

M.D. Board Of Director

Kirsten Green

Jules Maltz

David Wells

Lynne Chou O’keefe

Andrea Perez

Ambar Bhattacharyya

Dr. Patrick Carroll

About HIMS

Hims & Hers Healthの空売り状況は、投資家がHims & Hers Healthの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Hims & Hers Health (NYSE:HIMS) 株価情報, 空売り情報

Hims & Hers Health

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Hims & Hers Health, Inc. Class A Common Stock

Hims & Hers Health Inc

DA Davidson analyst Brian Holland maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and raises the price target from $183 to $189.

News

Price Target

Analyst Ratings

FRPT

DA Davidson Maintains Buy on Freshpet, Raises Price Target to $189

Hut 8 Says Its Self-Mining Produced 100 BTC In October, Up From 85 BTC In September; Vega Site Buildout Advancing On Track For Q2 2025 Energization

DA Davidson analyst Michael Shlisky maintains Federal Signal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSS#NYSE">FSS</a>) with a Neutral and lowers the price target from $94 to $90.

DA Davidson Maintains Neutral on Federal Signal, Lowers Price Target to $90

DA Davidson maintains NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) with a Buy and lowers the price target from $55 to $48.

NSSC

DA Davidson Maintains Buy on NAPCO Security Techs, Lowers Price Target to $48

Emerson and its affiliates currently own 57.4% of the Company's outstanding common shares, based on their most recent Schedule 13D filing dated November 5, 2024.
The Board of Directors of AspenTech will follow an appropriate governance process and carefully review the proposal. No action is required by AspenTech shareholders at this time. &nbsp;

AZPN

Aspen Technology Confirms Receipt Of $240/Share Unsolicited Acquisition Proposal From Emerson; Asks Shareholders Not To Take Any Action Pending Review

DA Davidson analyst Brent Thielman maintains Summit Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) with a Neutral and raises the price target from $41 to $47.

DA Davidson Maintains Neutral on Summit Materials, Raises Price Target to $47

Guidance

PAAS

Pan American Silver Reaffirms Its 2024 Operating Outlook For Annual Production, Cash Costs And AISC, And Capital Expenditures

Pan American Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.21 by 52.38 percent. This is a 3100 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $716.10 million which beat the analyst consensus estimate of $699.01 million by 2.44 percent. This is a 16.19 percent increase over sales of $616.30 million the same period last year.

Earnings

Earnings Beats

Pan American Silver Q3 2024 Adj EPS $0.32 Beats $0.21 Estimate, Sales $716.10M Beat $699.01M Estimate

DA Davidson analyst Kevin Fitzsimmons maintains Origin Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBK#NYSE">OBK</a>) with a Buy and lowers the price target from $41 to $38.

DA Davidson Maintains Buy on Origin Bancorp, Lowers Price Target to $38

DA Davidson analyst Gil Luria maintains Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) with a Neutral and raises the price target from $28 to $47.

PLTR

DA Davidson Maintains Neutral on Palantir Technologies, Raises Price Target to $47

The 2024 U.S. presidential election between Vice President Kamala Harris and former President Donald Trump remains one of the closest in history, raising concerns over whether the U.S. Supreme Court may play a decisive role in <a href="https://www.benzinga.com/topic/2024-election">determining the outcome. </a>
As voters head to the polls, election-related legal battles already hint at the possibility of judicial involvement, The New York Times <a href="https://www.nytimes.com/2024/11/05/us/politics/election-supreme-court.html">reports</a>.
What Happened: Several election cases have reached the Supreme Court in recent weeks, including a decision to allow Virginia's removal of over 1,600 voters from its rolls and rulings affecting candidates and voters in battleground states. 
The court decided against removing Robert F. Kennedy Jr. from ballots in key states and authorized provisional ballots in Pennsylvania, after some mail-in ballots were deemed invalid. These cases showcase the judiciary's cautious approach to electoral involvement, although the court's conservative majority could still play a critical role if a close race sparks significant litigation, according to The New York Times.
Also Read: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41759661/us-election-jitters-meet-interest-rate-cut-assurance-why-feds-powell-may-offer-tr">US Election Jitters Meet Interest-Rate Cut Assurance: Why Fed&#8217;s Powell May Offer Traders A Safe Harbor This Week</a>
The Supreme Court's involvement would hinge on an exceptionally narrow vote margin in a critical state, experts say. Prof. Richard Pildes of New York University told The New York Times that a paper-thin margin in a state like Pennsylvania, with its 19 electoral votes, could increase the likelihood of a court ruling influencing the presidential outcome.
Still, experts are cautious, noting that the Supreme Court generally aims to avoid direct involvement in elections.
Beyond the presidential race, the stakes extend to congressional control. Democrats seek to retain the Senate and flip the House, while Republicans push for gains in both chambers. The outcomes in Senate races, including those in Montana and Ohio, could shift control, particularly if Democratic seats in battleground states like Michigan and <a href="https://www.benzinga.com/general/politics/24/11/41725742/2024-election-stakes-potential-sweeps-split-outcomes-in-congressional-presidential-races">Pennsylvania face Republican challenges.</a> 
Why It Matters: A Supreme Court decision might not only impact the presidency but also influence control over Congress, setting a precedent for election litigation. In a scenario reminiscent of the Bush v. Gore case in 2000, if margins are close enough, legal challenges could escalate to the highest court. 
The potential for either party to control both chambers or split Congress suggests significant implications for the future of U.S. legislation and governance, The New York Times notes.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41756372/robinhoods-election-contracts-hit-200-million-trades-on-election-day">Robinhood&#8217;s Election Contracts Hit 200 Million Trades On Election Day</a></li>
</ul>
This article was generated using artificial intelligence and was reviewed by Benzinga editors.
Photo: Shutterstock

Government

Politics

Legal

Supreme Court Could Step In If 2024 Election Remains Deadlocked

SMCI

Super Micro Computer CEO Says Don't Expect Negative Allocation From NVIDIA

Super Micro Computer CEO Says He Has An 'Open Mind' About Separating CEO And Chairman Roles

Gerdau Reports Q3 Adjusted EBITDA Of R$3.0B, Up 14.9% Q/Q

Murchinson Ltd. holds approximately 7.1% of the outstanding shares of Nano Dimension.

NNDM

Murchinson Urges Nano Dimension Shareholders To Vote For Its Independent Nominees; Sends Letter Highlighting Company's Questionable Acquisitions

TD Bank Expects Catastrophe Claims Of $388M After Reinsurance And Before Tax To Be Reflected In Wealth Management & Insurance Segment's Q4 Results

Trump Media &amp; Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) reported third-quarter financial results after the market close Tuesday, the same day Donald Trump is facing off against Kamala Harris in the <a href="https://www.benzinga.com/news/24/11/41758791/whats-going-on-with-trump-media-technology-group-stock-tuesday">2024 presidential election.</a>
What Happened: Trump Media &amp; Technology Group announced third-quarter net sales of $1.01 million, down 6% year-over-year, according to data<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110524&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company <a href="https://s3.amazonaws.com/sec.irpass.cc/2660/0001140361-24-045260.pdf">said </a>all of its revenue came from advertising on the Truth Social platform in the quarter.
The company reported a loss of 10 cents per share compared to a loss of 30 cents per share in last year's third quarter.
Trump Media &amp; Technology Group, which was co-founded by the former president, highlighted the importance of Trump for the company's success.
"TMTG's success depends in part on the popularity of our brand and the reputation and popularity of President Donald J. Trump. The value of TMTG's brand may diminish if the popularity of President Donald J. Trump were to suffer," the company said.
Trump is able to post politically related posts on any social media site at any time, including outside of Truth Social, the filing said. 
The filing lists a date of Feb. 2, 2025 for when Trump may "terminate the Exclusivity Obligation" with 30 days prior written notice for his non-political posts to appear first on Truth Social.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent110524">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
What's Next: The quarterly filing said the company plans to roll out its streaming content in three phases.
<ul>
<li>Phase 1: Introduce Truth Social for streaming live TV to the Truth Social app for Android, iOS and Web</li>
<li>Phase 2: Release standalone Truth Social over-the-top streaming apps for phones, tablets and other devices</li>
<li>Phase 3: Release Truth Social streaming apps for home TV</li>
</ul>
The company said it completed phase 1 in August, phase 2 in October and as of Oct. 23, phase 3 has seen the Truth+ streaming platform released on Apple TV, Android TV and Amazon Fire TV.
Future growth initiatives from the company include growing the initial Truth Social platform, increasing product offerings and pursuing strategic acquisitions and/or partnerships.
The company said it plans to expand the business operations globally.
Trump Media &amp; Technology Group ended the third quarter with $672 million in cash, cash equivalents and short-term investments.
DJT Price Action: Shares of Trump Media &amp; Technology Group saw increased volatility Tuesday ahead of the 2024 election with shares halted twice Tuesday.
Shares traded between $31.45 and $40.74 on Tuesday before closing down 1% to $33.94.
The stock is trading 2,.2% higher after hours at $4.69. 
Trump Media &amp; Technology Group stock is likely to experience increased volatility during the week as investors await the results of the 2024 election, with a potential Trump win viewed as a positive for the stock and a Trump loss viewed as a negative for the stock.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41732623/bakery-that-often-predicts-election-outcomes-has-this-candidate-winning-in-trump-harris-battle-d" target="_blank" rel="noreferrer noopener">Bakery That Often Predicts Election Outcomes Has This Candidate Winning In Trump, Harris Battle: ‘Doughmacracy For All!'</a></li>
</ul>

Equities

Social Media

Markets

Movers

Trading Ideas

DJT Stock Volatile On Election Day: Donald Trump's Media Company Reports Q3 Earnings, Growth Initiatives

Jones Trading analyst Jason Weaver maintains Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) with a Buy and maintains $15 price target.

FBRT

Jones Trading Maintains Buy on Franklin BSP Realty Trust, Maintains $15 Price Target

Super Micro Computer CEO Says Its Servers Are Ready For Production When NVIDIA Chips Arrive

Gold Resource (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GORO#AMEX">GORO</a>) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.05) by 120 percent. This is a 37.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $13.27 million which missed the analyst consensus estimate of $16.66 million by 20.34 percent. This is a 35.42 percent decrease over sales of $20.55 million the same period last year.

Earnings Misses

GORO

Gold Resource Q3 EPS $(0.11) Misses $(0.05) Estimate, Sales $13.27M Miss $16.66M Estimate

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – QuinStreet&nbsp;(QNST)&nbsp;u...

Closing Bell Movers: Palantir jumps 13% after results

Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), Avanos Medical (AVNS...

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Avanos Medical (AVNS) and Alphatec Holdings (ATEC)

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q3 earnings. Here is a breakdown of the information Hims & Hers Health, Inc. presented to its...

Hims & Hers Health Reports Strong Q3 2024 Growth

Biggest stock movers Tuesday: CLF, PLTR, and more

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a pr...

Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)

Hims & Hers to launch a generic for Novo's older GLP-1

Seaport Global analyst Aaron Kessler maintained a Buy rating on Hims & Hers Health (HIMS – Research Report) today and set a price target of $32.00....

Seaport Global Sticks to Their Buy Rating for Hims & Hers Health (HIMS)

Hims & Hers Health: Another Blowout Quarter Ignored

ALAB

ATEC

ATUS

AVNS

BOOM

BOWL

CRUS

DLTR

EVER

FANG

FWRD

GKOS

HDSN

HOLX

ILMN

LSCC

NONOF

NXPI

QNST

SLAB

VMEO

VRTX

WYNN

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

General

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Health Care

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future

Press Releases

Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

Hims & Hers Health Set to Join S&P SmallCap 600

Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

Define Ventures Appoints Bruce Broussard as Venture Partner

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

GDRX

SPGI

TDOC

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Holdings

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

Option Care Health

Premier

Pennant Gr

Privia Health Gr

R1 RCM

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Hldgs

Piper Sandler

Canaccord Genuity

B of A Securities

Needham

Deutsche Bank

WIIM

Hims & Hers Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 revenue guidance above estimates.

Comments

Hims & Hers Health

空売り

Hims & Hers Health (NYSE:HIMS) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル